These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
603 related articles for article (PubMed ID: 33824205)
61. New Roles for Fusobacterium nucleatum in Cancer: Target the Bacteria, Host, or Both? Slade DJ Trends Cancer; 2021 Mar; 7(3):185-187. PubMed ID: 33309240 [TBL] [Abstract][Full Text] [Related]
62. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer. Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912 [TBL] [Abstract][Full Text] [Related]
64. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine. Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935 [TBL] [Abstract][Full Text] [Related]
65. Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients. Boehm ET; Thon C; Kupcinskas J; Steponaitiene R; Skieceviciene J; Canbay A; Malfertheiner P; Link A Sci Rep; 2020 Oct; 10(1):16240. PubMed ID: 33004953 [TBL] [Abstract][Full Text] [Related]
66. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade. Wu Y; Wu J; Chen T; Li Q; Peng W; Li H; Tang X; Fu X Dig Dis Sci; 2018 May; 63(5):1210-1218. PubMed ID: 29508166 [TBL] [Abstract][Full Text] [Related]
67. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load. Rye MS; Garrett KL; Holt RA; Platell CF; McCoy MJ PLoS One; 2022; 17(1):e0262416. PubMed ID: 34995318 [TBL] [Abstract][Full Text] [Related]
68. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Zepeda-Rivera M; Minot SS; Bouzek H; Wu H; Blanco-Míguez A; Manghi P; Jones DS; LaCourse KD; Wu Y; McMahon EF; Park SN; Lim YK; Kempchinsky AG; Willis AD; Cotton SL; Yost SC; Sicinska E; Kook JK; Dewhirst FE; Segata N; Bullman S; Johnston CD Nature; 2024 Apr; 628(8007):424-432. PubMed ID: 38509359 [TBL] [Abstract][Full Text] [Related]
69. Fusobacterium nucleatum, immune responses, and metastatic organ diversity in colorectal cancer liver metastasis. Shigematsu Y; Saito R; Amori G; Kanda H; Takahashi Y; Takeuchi K; Takahashi S; Inamura K Cancer Sci; 2024 Oct; 115(10):3248-3255. PubMed ID: 39140431 [TBL] [Abstract][Full Text] [Related]
70. Both endogenous and exogenous miR-139-5p inhibit Fusobacterium nucleatum-related colorectal cancer development. Zhao Y; Tao Q; Li S; Zheng P; Liu J; Liang X Eur J Pharmacol; 2020 Dec; 888():173459. PubMed ID: 32768506 [TBL] [Abstract][Full Text] [Related]
71. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions. Kumar A; Thotakura PL; Tiwary BK; Krishna R BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600 [TBL] [Abstract][Full Text] [Related]
72. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients. Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996 [TBL] [Abstract][Full Text] [Related]
73. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue. Mehta RS; Nishihara R; Cao Y; Song M; Mima K; Qian ZR; Nowak JA; Kosumi K; Hamada T; Masugi Y; Bullman S; Drew DA; Kostic AD; Fung TT; Garrett WS; Huttenhower C; Wu K; Meyerhardt JA; Zhang X; Willett WC; Giovannucci EL; Fuchs CS; Chan AT; Ogino S JAMA Oncol; 2017 Jul; 3(7):921-927. PubMed ID: 28125762 [TBL] [Abstract][Full Text] [Related]
74. Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort. Gong D; Adomako-Bonsu AG; Wang M; Li J PeerJ; 2023; 11():e15777. PubMed ID: 37554340 [TBL] [Abstract][Full Text] [Related]
75. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study. Shariati A; Razavi S; Ghaznavi-Rad E; Jahanbin B; Akbari A; Norzaee S; Darban-Sarokhalil D Infect Agent Cancer; 2021 Jun; 16(1):41. PubMed ID: 34108031 [TBL] [Abstract][Full Text] [Related]
77. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer. Kwong TNY; Wang X; Nakatsu G; Chow TC; Tipoe T; Dai RZW; Tsoi KKK; Wong MCS; Tse G; Chan MTV; Chan FKL; Ng SC; Wu JCY; Wu WKK; Yu J; Sung JJY; Wong SH Gastroenterology; 2018 Aug; 155(2):383-390.e8. PubMed ID: 29729257 [TBL] [Abstract][Full Text] [Related]
78. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer. Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471 [TBL] [Abstract][Full Text] [Related]
79. The Intestinal Microbiota and Colorectal Cancer. Cheng Y; Ling Z; Li L Front Immunol; 2020; 11():615056. PubMed ID: 33329610 [TBL] [Abstract][Full Text] [Related]
80. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis. Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]